NasdaqGS - Nasdaq Real Time Price
USD
BridgeBio Pharma, Inc. (BBIO)
74.19
+3.46
(+4.89%)
As of 2:59:49 PM EDT. Market Open.
Trade BBIO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| APULI MARICEL Officer |
Sale | Jul 30, 2026 | 127,401 |
| HOMCY CHARLES J Director |
Stock Award(Grant) | Jun 22, 2026 | 919,876 |
| KKR GENETIC DISORDER L.P. Beneficial Owner of more than 10% of a Class of Security |
Sale | May 12, 2025 | -- |
| KUMAR NEIL Chief Executive Officer |
Sale | Sep 17, 2026 | -- |
| MCCORMICK FRANK P. PH.D. Director |
Stock Award(Grant) | Jun 22, 2026 | 767,244 |
| MOMTAZEE JAMES C Director |
Stock Award(Grant) | Jun 22, 2026 | 99,070 |
| SATVAT ALI J Director |
Stock Award(Grant) | Jun 22, 2026 | 169,983 |
| STEPHENSON BRIAN C Chief Financial Officer |
Conversion of Exercise of derivative security | Feb 25, 2025 | 102,464 |
| TRIMARCHI THOMAS President |
Sale | May 18, 2026 | 359,194 |
| VIKING GLOBAL INVESTORS LP Beneficial Owner of more than 10% of a Class of Security |
Sale | Jun 27, 2025 | -- |
